When A Diabetic Foot Ulcer Is Complicated With Tophaceous Gout
- Volume 26 - Issue 4 - April 2013
- 8064 reads
- 0 comments
Dr. Davidson is Chief of the Podiatry Section of the Department of Orthopedics with the Kaleida Health System in Western New York. he is on medical staff of the Center for Wound Care & Hyperbabric Medicine at The Erie County Medical Center. He is an Assistant Clinical Professor in the Department of Orthopedics at the State University of New York at Bffalo School of Medicine and Biomedical Sciences. Dr. Davidson is a past President of the American Board of Podiatric Orthopedics. He is a past President and Fellow of the American Academy of Podiatric Sports Medicine. Dr. Davidson is a Diplomate of the American Board of Podiatric Surgery and the American Board of Podiatric Orthopedics and Primary Podiatric Medicine. He is in private practice with multiple office locations in Western New York.
1. Whitehouse FW, Cleary WJ Jr. Diabetes mellitus in patients with gout. JAMA. 1966;197(2):73-6.
2. Bartels EC, Balodimos MC, Corn LR. The association of gout and diabetes mellitus. Med Clin North Amer. 1960;44:433-438.
3. Dunn JS, Sheehan HL, McLetchie NGB. Necrosis of islets of Langerhand produced experimentally. Lancet. 1993:1:484-7.
4. Liu Q, Gamble G, Pickering K, Morton D, Dalbeth N. Prevalence and clinical factors associated with gout in patients with diabetes and prediabetes. Rheumatology (Oxford). 2012;51(4):757-759.
5. Zhu Y, Zhang Y, Choi HK. The serum urate-lowering impact of weight loss among men with a high cardiovascular risk profile: the Multiple Risk Factor Intervention Trial. Rheumatology (Oxford). 2010;49(12): 2391-2399
6. Rodriguez G, Soriano LC, Choi HK. Impact of diabetes against the future risk of developing gout. Ann Rheum Dis. 2010;69(12):2090-2094.
7. Dao HH, Harun-Or-Rashid M, Sakamoto J. Body composition and metabolic syndrome in patients with primary gout in Vietnam. Rheumatology (Oxford). 2010;49(12):2400-2407.
8. Rider TG, Jordan KM. The modern management of gout. Rheumatology (Oxford). 2010;49(1): 5-14.
9. Roddy E, Mallen CD, Hider SL, Jordan KP. Prescription and comorbidity screening following consultation for acute gout in primary care. Rheumatology (Oxford). 2010;49(1):105-111.
10. Kim SY, Choi HK. Gout and quality of life. J Rheumatology. 2009;36(5): 865-868.
11. Doherty M. New insights into the epidemiology of gout. Rheumatology (Oxford). 2009;48 Suppl 2:ii2-ii8.
12. Samaras N, Rossi C. Images in clinical medicine. Tophaceous gout. N Engl J Med. 2012;366(3):e6.
13. Dobson M, Alwahab Y, Fazal MA. Interphalangeal joint involvement of the big toe. J Am Podiatr Med Assoc. 2012;102(3):256-258.
14. Winnard D, Wright C, Taylor WJ, et al. National prevalence of gout derived from administrative health data in Aotearoa, New Zealand. Rheumatology (Oxford). . 2012;51(5): 901-909.